Genoma Enters Top Tier Of Local Companies

BMI View: Given Mexico's uncertain macroeconomic outlook, pharmaceutical companies in the country will optimise revenue growth potential in the medium term by increasing their market share in the Mexican generic medicine segment. Expansion into other emerging markets in the region, such as Brazil, will be key to ensuring long-term growth.

To read the full article, please choose one of the following options: